(CTOR) Citius Oncology - Performance -98.2% in 12m
Compare CTOR with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-41.74%
#25 in Group
Rel. Strength
0.26%
#8012 in Universe
Total Return 12m
-98.20%
#49 in Group
Total Return 5y
-98.20%
#49 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -4.06%
14th Percentile in Group
12m Total Return: CTOR (-98.2%) vs XLV (0.3%)
5y Drawdown (Underwater) Chart
Top Performers in Life Sciences Tools & Services
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| A NYSE Agilent Technologies |
-11.6% | -21.5% | 44.2% | 23.5 | 18.4 | 1.68 | 58.4% | 7.8% |
| RVTY NYSE Revvity |
-12.1% | -7.4% | 7.42% | 39 | 18.2 | 0.64 | -63.9% | -30.6% |
| TECH NASDAQ Bio-Techne |
-16.2% | -19.5% | -1.48% | 51.8 | 22.6 | 1.07 | -31.9% | -5.85% |
| SHC NASDAQ Sotera Health |
-6.5% | -1.46% | -55.6% | 65.6 | 20.2 | 1.68 | -43.6% | - |
Performance Comparison: CTOR vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for CTOR
| Total Return (including Dividends) | CTOR | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -8.19% | -4.97% | -4.31% |
| 3 Months | -42.60% | -6.08% | -7.85% |
| 12 Months | -98.20% | 0.26% | 10.76% |
| 5 Years | -98.20% | 47.01% | 106.31% |
| Trend Score (consistency of price movement) | CTOR | XLV | S&P 500 |
| 1 Month | -36.6% | -54.4% | -35.6% |
| 3 Months | -84.5% | -66.1% | -89.7% |
| 12 Months | -73.2% | -12% | 58.3% |
| 5 Years | -73.2% | 90% | 84.2% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
| 1 Month | #22 | -3.38% | -4.05% |
| 3 Month | #39 | -38.9% | -37.7% |
| 12 Month | #50 | -98.1% | -98.3% |
| 5 Years | #49 | -98.1% | -98.3% |
FAQs
Does CTOR Citius Oncology outperforms the market?
No,
over the last 12 months CTOR made -98.20%, while its related Sector, the Health Care Sector SPDR (XLV) made 0.26%.
Over the last 3 months CTOR made -42.60%, while XLV made -6.08%.
Over the last 3 months CTOR made -42.60%, while XLV made -6.08%.
Performance Comparison CTOR vs Indeces and Sectors
CTOR vs. Indices CTOR is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 10.2% | -3.88% | -34.5% | -109% |
| US NASDAQ 100 | QQQ | 8.28% | -3.95% | -34.5% | -110% |
| US Dow Jones Industrial 30 | DIA | 12.3% | -2.41% | -34.8% | -105% |
| German DAX 40 | DAX | 12.9% | -4.38% | -53.0% | -122% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 16.8% | -4.69% | -33.1% | -107% |
| Hongkong Hang Seng | HSI | 12.5% | -5.31% | -36.4% | -112% |
| India NIFTY 50 | INDA | 17.7% | -9.75% | -36.1% | -100% |
| Brasil Bovespa | EWZ | 10.5% | -10.2% | -39.0% | -92.7% |
CTOR vs. Sectors CTOR is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 10.4% | -2.61% | -43.3% | -121% |
| Consumer Discretionary | XLY | 7.89% | -4.15% | -37.7% | -113% |
| Consumer Staples | XLP | 17.7% | -10.9% | -39.9% | -108% |
| Energy | XLE | 13.6% | 3.44% | -32.1% | -86.3% |
| Financial | XLF | 12.2% | -3.41% | -42.6% | -118% |
| Health Care | XLV | 13.3% | -3.22% | -32.5% | -98.5% |
| Industrial | XLI | 12.1% | -4.12% | -34.9% | -105% |
| Materials | XLB | 13.5% | -3.68% | -27.7% | -92.9% |
| Real Estate | XLRE | 15.1% | -6.28% | -32.4% | -113% |
| Technology | XLK | 6.43% | -3.67% | -29.7% | -104% |
| Utilities | XLU | 14.4% | -9.87% | -37.6% | -119% |
| Aerospace & Defense | XAR | 10.7% | -7.89% | -45.8% | -125% |
| Biotech | XBI | 11.1% | -0.35% | -21.5% | -96.0% |
| Homebuilder | XHB | 12.0% | -2.17% | -19.6% | -90.2% |
| Retail | XRT | 13.0% | -5.26% | -30.4% | -94.6% |